Skip to main content

Table 3 Foundation one histology distribution

From: A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis

Disease n All CDKN2A Copy # Rearrangements SNV: somatic SNV: germline SNV: unknown SNV: all Multiple alterations
All soft tissue sarcoma 7733 16.7 14.0 0.4 1.1 0.2 0.7 2.0 0.3
Malignant peripheral nerve sheath tumor (MPNST) 262 60.7 48.1 5.3 5.0 0.4 1.5 6.9 0.4
Myxofibrosarcoma 140 29.3 23.6 1.4 2.1 0.7 0.7 3.6 0.7
Undifferentiated pleomorphic sarcoma (UPS) 372 29 21.5 0.3 5.1 0.0 1.3 6.5 0.8
Soft tissue sarcoma (NOS) 1476 28.9 25.4 0.4 1.3 0.3 1.1 2.6 0.5
Fibrosarcoma 99 26.3 22.2 0.0 2.0 0.0 1.0 3.0 1.0
Clear cell sarcoma 72 23.6 18.1 0.0 0.0 1.4 2.8 4.2 1.4
Epithelioid sarcoma 72 20.8 18.1 0.0 2.8 0.0 0.0 2.8 0.0
Perivascular epithelioid cell tumor (PEComa) 58 20.7 15.5 0.0 1.7 1.7 1.7 5.2 0.0
Angiosarcoma 292 20.2 16.4 0.3 1.7 0.3 1.0 3.1 0.3
Endometrial stromal sarcoma 200 15 12.5 0.0 0.5 0.0 2.0 2.5 0.0
Rhabdomyosarcoma (Embryonal) 96 14.6 10.4 2.1 1.0 0.0 1.0 2.1 0.0
Rhabdomyosarcoma (NOS) 199 14.1 12.1 0.0 2.0 0.0 0.0 2.0 0.0
Hemangioendothelioma 68 10.3 7.4 0.0 2.9 0.0 0.0 2.9 0.0
Uterus leiomyosarcoma 678 10.2 9.3 0.3 0.1 0.1 0.1 0.4 0.1
Inflammatory myofibroblastic tumor 62 9.7 8.1 0.0 0.0 0.0 0.0 0.0 1.6
Uterus sarcoma (NOS) 129 9.3 8.5 0.8 0.0 0.0 0.0 0.0 0.0
Unknown primary leiomyosarcoma 206 8.7 7.8 0.0 0.0 0.0 1.0 1.0 0.0
Rhabdomyosarcoma (Alveolar) 101 6.9 5.0 0.0 0.0 1.0 1.0 2.0 0.0
Leiomyosarcoma 924 6.4 5.2 0.0 0.4 0.2 0.3 1.0 0.2
Solitary fibrous tumor 149 6 6.0 0.0 0.0 0.0 0.0 0.0 0.0
Breast angiosarcoma 70 5.7 5.7 0.0 0.0 0.0 0.0 0.0 0.0
Synovial sarcoma 321 5 4.0 0.0 0.0 0.0 0.6 0.6 0.3
Liposarcoma 805 5 4.5 0.1 0.1 0.1 0.1 0.4 0.0
Desmoplastic small round cell tumor 113 4.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0
Alveolar soft part sarcoma (ASPS) 72 4.2 2.8 0.0 1.4 0.0 0.0 1.4 0.0